PSP Research LLC

CIK 0002106939 · LAS VEGAS, NV · Quarter end: 2026-06-30 · Filed on: 2026-07-09 · Open the SEC source

PSP Research LLC reported 75 positions worth $187.9M as of June 30, 2026 (13F filed July 9, 2026). Largest holding: XBI (48.0%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$187.9M
2026 Q2
Positions
75
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
88.0%
Est. Net Flow (Q)
2026 Q2
10 / 75 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1XBISPDR SERIES TRUSTSH$90.2M48.01%570,000
2SGOVISHARES TRSH$70.5M37.51%700,000
3RPRXROYALTY PHARMA PLCSH$616.8K0.33%11,000
4NRIXNURIX THERAPEUTICS INCSH$606.5K0.32%25,000
5INCYINCYTE CORPSH$600.8K0.32%5,300
6ARGXARGENX SESH$594.7K0.32%641
7IRONDISC MEDICINE INCSH$585.1K0.31%8,000
8RAPPRAPPORT THERAPEUTICS INCSH$583.4K0.31%14,000
9RAREULTRAGENYX PHARMACEUTICAL INSH$567.6K0.30%17,000
10TRVITREVI THERAPEUTICS INCSH$559.5K0.30%30,000

The free plan shows the top 10 positions. The remaining 65 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does PSP Research LLC hold as of Q2 2026?

PSP Research LLC reported 75 positions worth $187.9M in its Q2 2026 13F filing. Largest positions: XBI (48.0%), SGOV (37.5%), RPRX (0.3%), NRIX (0.3%) and INCY (0.3%).

What did PSP Research LLC buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did PSP Research LLC sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.